Other

Roche sees pharma market recovering from COVID

Swiss pharmaceutical firm Roche said Thursday that drug sales have begun to recover from a COVID-induced slump as it confirmed forecasts for a modest increase in sales for the year as a whole.

Vaccination

AstraZeneca Covid vaccine sales hit $275 mn in first quarter

British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company's performance in the face ...

Other

Novartis profit up as world flocks to buy medecine

Swiss pharma giant Novartis on Tuesday reported higher profits for the first quarter as customers rushing to buy treatments during the coronavirus outbreak boosted the bottom line.

Other

Bayer Q2 profits jump on new drugs, lower charges (Update)

German drug and chemicals company Bayer AG says net profit rose 75 percent in the second quarter thanks to lower one-time charges and strong sales of new products including anti-clotting drug Xarelto and cancer drug Stivarga.

Other

Higher prices for MS drug help drug firm Merck

(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.

Medications

Lundbeck profit jumps but warns on generic pressure

Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.

Medications

Bayer profits up 11.5 percent on new drugs

German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.

page 1 from 2